E
Etienne Gayat
Researcher at University of Paris
Publications - 318
Citations - 8081
Etienne Gayat is an academic researcher from University of Paris. The author has contributed to research in topics: Medicine & Heart failure. The author has an hindex of 42, co-authored 276 publications receiving 6048 citations. Previous affiliations of Etienne Gayat include Saint Louis University Hospital & Paris Diderot University.
Papers
More filters
Journal ArticleDOI
Association between systemic hemodynamics and septic acute kidney injury in critically ill patients: a retrospective observational study.
Matthieu Legrand,Claire Dupuis,Christelle Simon,Etienne Gayat,Etienne Gayat,Joaquim Mateo,Anne Claire Lukaszewicz,Anne Claire Lukaszewicz,Didier Payen,Didier Payen +9 more
TL;DR: In this paper, the authors investigated the association between systemic hemodynamics and new or persistent acute kidney injury (AKI) in severe sepsis, and found no association between most systemic hemodynamic parameters and AKI in septic patients.
Journal ArticleDOI
Clinical presentation, management and outcomes in the Acute Heart Failure Global Survey of Standard Treatment (ALARM-HF)
Ferenc Follath,Mehmet Yilmaz,Mehmet Yilmaz,Juan F. Delgado,John Parissis,Raphaël Porcher,Etienne Gayat,Nigel Burrows,Anthony S. McLean,Fábio Vilas-Boas,Alexandre Mebazaa +10 more
TL;DR: The authors' data demonstrated the existence of different subgroups based on de novo or pre-existing episode(s) of AHF and the site of hospitalization and recognition of these subgroups might improve management and outcome by defining specific therapeutic requirements.
Journal ArticleDOI
Incremental value of biomarkers to clinical variables for mortality prediction in acutely decompensated heart failure: The Multinational Observational Cohort on Acute Heart Failure (MOCA) study
Johan Lassus,Johan Lassus,Etienne Gayat,Christian Mueller,W. Frank Peacock,Jindrich Spinar,Veli-Pekka Harjola,Roland R.J. van Kimmenade,Atul Pathak,Thomas Mueller,Salvatore DiSomma,Marco Metra,Domingo A. Pascual-Figal,Said Laribi,Said Laribi,Damien Logeart,Semir Nouira,Naoki Sato,Michael Potocki,Jiri Parenica,Corinne Collet,Alain Cohen-Solal,James L. Januzzi,Alexandre Mebazaa +23 more
TL;DR: Biomarkers such as sST2, MR-proADM, natriuretic peptides and CRP, reflecting different pathophysiologic pathways, add prognostic value to clinical risk factors for predicting both short-term and one-year mortality in ADHF.
Journal ArticleDOI
Body Mass Index and Mortality in Acutely Decompensated Heart Failure Across the World: A Global Obesity Paradox
Ravi V. Shah,Etienne Gayat,James L. Januzzi,Naoki Sato,Alain Cohen-Solal,Salvatore DiSomma,Enrique Fairman,Veli-Pekka Harjola,Shiro Ishihara,Johan Lassus,Aldo P. Maggioni,Marco Metra,Christian Mueller,Thomas Mueller,Jiri Parenica,Domingo A. Pascual-Figal,William F. Peacock,Jindrich Spinar,Roland R.J. van Kimmenade,Alexandre Mebazaa +19 more
TL;DR: The "obesity paradox" is confined to older persons, with decreased cardiac function, less cardiometabolic illness, and recent-onset HF, suggesting that aging, HF severity/chronicity, and metabolism may explain the obesity paradox.
Journal ArticleDOI
Short-term survival by treatment among patients hospitalized with acute heart failure: the global ALARM-HF registry using propensity scoring methods
Alexandre Mebazaa,John Parissis,Raphaël Porcher,Raphaël Porcher,Etienne Gayat,Etienne Gayat,Maria Nikolaou,Fabio Vilas Boas,Juan F. Delgado,Ferenc Follath +9 more
TL;DR: In terms of in-hospital survival, a vasodilator in combination with a diuretic fared better than treatment with only a diUREtic, and catecholamine inotropes should be used cautiously as it has been seen that they actually increase the risk for in- hospital mortality.